Timing of initiation of sodium-glucose co-transporter 2 inhibitor in patients with diabetes and chronic cardiac failure

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Wen Sun

The Chinese University of Hong Kong, Shatin (Hong Kong)

5 More presentations in this session

Presentation thumbnail

Biomarker profiles and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome

Miss C. van der Hoef (Groningen, NL)

Abstract Slides

Presentation thumbnail

Diabetes may modify the efficacy of primary prevention implantable cardioverter-defibrillators in non-ischemic systolic heart failure: an extended follow-up of the DANISH trial

Doctor S. N Doi (Copenhagen, DK)

Abstract Slides

Presentation thumbnail

Prediabetes relates to impaired mitochondrial function in human ventricular myocardium

Mr E. Zweck (Duesseldorf, DE)

Abstract Slides

Presentation thumbnail

Outcomes in hospitalised diabetic ketoacidosis patients with underlying heart failure: a national inpatient sample analysis

Doctor S. Yalamanchili (Greenville, US)

Abstract Slides

Presentation thumbnail

Risk of heart failure following short-term non-steroidal anti-inflammatory drug use in patients with type 2 diabetes mellitus

Mr J. Strange (Copenhagen, DK)

Abstract Slides

Access the full session

Session thumbnail

Chronic heart failure and diabetes

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Presentation

Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion

Congress Presentation

The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources